Skip to menu Skip to content Skip to footer

2006

Book Chapter

Primary mineralocorticoid excess syndromes

Edwards, Christopher R. W. and Stowasser, Michael (2006). Primary mineralocorticoid excess syndromes. Endocrinology. (pp. 2461-2490) edited by L. J. DeGroot and J. L. Jameson. USA: Elsevier Saunders.

Primary mineralocorticoid excess syndromes

2006

Conference Publication

No evidence of mutations in RBAK and PMS2 in association with familial hyperaldosteronism type II

So, A., Jeske, Y., Gordon, R. D., Duffy, D., Kelemen, L. and Stowasser, M. (2006). No evidence of mutations in RBAK and PMS2 in association with familial hyperaldosteronism type II. 21st Scientific Meeting of the International Society of Hypertension, Fukuoka, Japan, 15 to 19 October 2006. Japan: International Society of Hypertension.

No evidence of mutations in RBAK and PMS2 in association with familial hyperaldosteronism type II

2006

Conference Publication

Prevalence of primary aldosteronism among Chinese hypertensive patients

Gong, Y., Zhu, D., Zhang,, Chen, S. L., Chu, S.X., Zhang, L.H., Stowasser, M. and Gordon, R. D. (2006). Prevalence of primary aldosteronism among Chinese hypertensive patients. 21st Scientific Meeting of the International Society of Hypertension, Fukuoka, Japan, 15th to 19th October, 2006. Japan: International Society of Hypertension.

Prevalence of primary aldosteronism among Chinese hypertensive patients

2006

Conference Publication

Lipoprotein (a) is elevated in patients with renovascular hypertension, but not in patients with primary aldosteronism

Kostner, K., Liu, Y., Cowley, D. and Stowasser, M. (2006). Lipoprotein (a) is elevated in patients with renovascular hypertension, but not in patients with primary aldosteronism. ISA 2006: XIV International Symposium on Atherosclerosis, Rome, Italy, 18-22 June 2006. E. Park, Shannon, Co. Clare, Ireland: Elsevier Ireland. doi: 10.1016/S1567-5688(06)81883-0

Lipoprotein (a) is elevated in patients with renovascular hypertension, but not in patients with primary aldosteronism

2006

Book Chapter

The hypertensive accountant

Stowasser, Michael and Gordon, Richard D. (2006). The hypertensive accountant. Tietz's applied laboratory medicine. (pp. 175-182) edited by G. M. Scott, A. M. Gronowski, C. S. Eby and N. W. Tietz. Hoboken, N.J.: Wiley-Interscience. doi: 10.1002/9780470086087.ch23

The hypertensive accountant

2005

Journal Article

Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism type I

Stowasser, Michael, Sharman, James, Leano, Rodel, Gordon, Richard D., Ward, Gregory, Cowley, Diane and Marwick, Thomas H. (2005). Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism type I. Journal of Clinical Endocrinology and Metabolism, 90 (9), 5070-5076. doi: 10.1210/jc.2005-0681

Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism type I

2005

Journal Article

Familial hyperaldosteronism type II is linked to the chromosome 7p22 region but also shows predicted heterogeneity

So, A, Duffy, DL, Gordon, RD, Jeske, YWA, Lin-Su, K, New, MI and Stowasser, M (2005). Familial hyperaldosteronism type II is linked to the chromosome 7p22 region but also shows predicted heterogeneity. Journal of Hypertension, 23 (8), 1477-1484. doi: 10.1097/01.hjh.0000174299.66369.26

Familial hyperaldosteronism type II is linked to the chromosome 7p22 region but also shows predicted heterogeneity

2005

Conference Publication

Genomic structure of the human gene for protein kinase A regulatory subunit R1-beta (PRKAR1B) on 7p22: No evidence for mutations in familial hyperaldosteronism type II in a large affected kindred

Stowasser, M, Elphinstone, M, So, A, Jeske, Y and Gordon, R (2005). Genomic structure of the human gene for protein kinase A regulatory subunit R1-beta (PRKAR1B) on 7p22: No evidence for mutations in familial hyperaldosteronism type II in a large affected kindred. 26th Annual Scientific Meeting of the High-Blood-Pressure-Research-Council-of-Australia, Sydney Australia, Nov 24-26, 2004. OXFORD: BLACKWELL PUBLISHING.

Genomic structure of the human gene for protein kinase A regulatory subunit R1-beta (PRKAR1B) on 7p22: No evidence for mutations in familial hyperaldosteronism type II in a large affected kindred

2005

Journal Article

Left ventricular mass in patients with type 2 diabetes is independently associated with central but not peripheral pulse pressure

Sharman, James E., Fang, Zhi Y., Haluska, Brian, Stowasser, Michael, Prins, Johannes B. and Marwick, Thomas H. (2005). Left ventricular mass in patients with type 2 diabetes is independently associated with central but not peripheral pulse pressure. Diabetes Care, 28 (4), 937-939. doi: 10.2337/diacare.28.4.937

Left ventricular mass in patients with type 2 diabetes is independently associated with central but not peripheral pulse pressure

2005

Conference Publication

Further evidence of linkage at 7p22 with familial hyperaldosteronism type II

So, Albertina, Stowasser, Michael, Gordon, Richard, Duffy, David and Jeske, Yvette (2005). Further evidence of linkage at 7p22 with familial hyperaldosteronism type II. 20th Annual Scientific Meeting of the American Society of Hypertension, San Francisco, USA, 14-18 May 2005. Elsevier Inc: New York, USA. doi: 10.1016/j.amjhyper.2005.03.659

Further evidence of linkage at 7p22 with familial hyperaldosteronism type II

2005

Book Chapter

Overview of mineralocorticoid excess syndromes

Gordon, Richard D. and Stowasser, Michael (2005). Overview of mineralocorticoid excess syndromes. Adrenal glands: Diagnostic aspects and surgical therapy. (pp. 115-126) edited by Dimitrios Linos and Jon A. van Heerden. Berlin: Springer.

Overview of mineralocorticoid excess syndromes

2005

Conference Publication

Lack of association in Australian patients with primary aldosteronism (PAL) of the aldosterone synthase CYP11B2 gene polymorphisms,-344C/T or intron2 conversion

Stowasser, M, Jeske, Y., So, A., Gordon, R. and Duffy, D. (2005). Lack of association in Australian patients with primary aldosteronism (PAL) of the aldosterone synthase CYP11B2 gene polymorphisms,-344C/T or intron2 conversion. The 26th Annual Scientific Meeting of the High Blood Pressure Research Council of Australia Inc., Sydney, Australia, 24-26 November, 2004. Oxford: Blackwell Scientific Publications.

Lack of association in Australian patients with primary aldosteronism (PAL) of the aldosterone synthase CYP11B2 gene polymorphisms,-344C/T or intron2 conversion

2005

Conference Publication

No association between primary aldosteronism and two CYP11B2 polymorphisms in a well-characterized Australian sample

Jeske, Y., So, A., Gordon, R. D., Duffy, D. and Stowasser, M. (2005). No association between primary aldosteronism and two CYP11B2 polymorphisms in a well-characterized Australian sample. 20th Annual Scientific Meeting of the American Society of Hypertension, San Francisco, U.S.A., 14-18 May 2005. New York, U.S.A.: Nature Publishing Group. doi: 10.1016/j.amjhyper.2005.03.012

No association between primary aldosteronism and two CYP11B2 polymorphisms in a well-characterized Australian sample

2005

Conference Publication

Familial hyperaldosteronism type II (FH-II): Further evidence for linkage at chromosome 7p22 but also for the predicted genetic heterogeneity

So, A., Stowasser, M., Gordon, R., Duffy, D. and Jeske, Y. (2005). Familial hyperaldosteronism type II (FH-II): Further evidence for linkage at chromosome 7p22 but also for the predicted genetic heterogeneity. The 26th Annual Scientific Meeting of the High Blood Pressure Research Council of Australia Inc., Sydney, Australia, 24-26 November, 2004. Blackwell Scientific Publications: BLACKWELL PUBLISHING.

Familial hyperaldosteronism type II (FH-II): Further evidence for linkage at chromosome 7p22 but also for the predicted genetic heterogeneity

2005

Conference Publication

Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism type I

Stowasser, Michael, Sharman, James, Leano, Rodel, Gordon, Richard, Ward, Gregory, Cowley, Diane and Marwick, Thomas (2005). Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism type I. 20th Annual Scientific Meeting of the American Society of Hypertension, San Francisco, CA, USA, 14 - 18 May, 2005. USA: Elsevier Inc. doi: 10.1016/j.amjhyper.2005.03.648

Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism type I

2004

Journal Article

Genomic structure of the human gene for protein kinase A regulatory subunit R1-beta (PRKAR1B) on 7p22: No evidence for mutations in familial hyperaldosteronism type II in a large affected kindred

Elphinstone, Martin S., Gordon, Richard D., So, Albertina, Jeske, Yvette W. A., Stratakis, Constantine A. and Stowasser, Michael (2004). Genomic structure of the human gene for protein kinase A regulatory subunit R1-beta (PRKAR1B) on 7p22: No evidence for mutations in familial hyperaldosteronism type II in a large affected kindred. Clinical Endocrinology, 61 (6), 716-723. doi: 10.1111/j.1365-2265.2004.02155.x

Genomic structure of the human gene for protein kinase A regulatory subunit R1-beta (PRKAR1B) on 7p22: No evidence for mutations in familial hyperaldosteronism type II in a large affected kindred

2004

Journal Article

The aldosterone-renin ratio in screening for primary aldosteronism

Stowasser, Michael and Gordon, Richard D. (2004). The aldosterone-renin ratio in screening for primary aldosteronism. Endocrinologist, 14 (5), 267-276. doi: 10.1097/01.ten.0000139006.29471.9e

The aldosterone-renin ratio in screening for primary aldosteronism

2004

Conference Publication

Myocardial dysfunction in hypertensive patients with isolated diastolic heart failure is reversible. A randomized trial of aldosterone antagonism

Mottram, PM, Haluska, BA, Leano, R, Cowley, D, Stowasser, M and Marwick, TH (2004). Myocardial dysfunction in hypertensive patients with isolated diastolic heart failure is reversible. A randomized trial of aldosterone antagonism. ESC Congress 2004, Munich Germany, Aug 28-Sep 01, 2004.

Myocardial dysfunction in hypertensive patients with isolated diastolic heart failure is reversible. A randomized trial of aldosterone antagonism

2004

Conference Publication

Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents

Mulatero, P, Stowasser, M, Loh, KC, Fardella, CE, Gordon, RD, Mosso, L, Gomez-Sanchez, CE, Veglio, F and Young, WF (2004). Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. 14th European Meeting on Hypertension, Paris France, Jun 13-17, 2004. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. doi: 10.1097/00004872-200406002-00629

Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents

2004

Conference Publication

Is primary aldosteronism associated with abnormal myocardial function independent of blood pressure?

Stowasser, M, Mottram, P, Leano, R, Klaassen, P, Cowley, D and Marwick, T (2004). Is primary aldosteronism associated with abnormal myocardial function independent of blood pressure?. 30th International Geographical Congress 2004, Glasgow Scotland, Aug, 2004. CARLTON: LIPPINCOTT WILLIAMS & WILKINS.

Is primary aldosteronism associated with abnormal myocardial function independent of blood pressure?